Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity

Deiodinase type II (D2), encoded by DIO2, catalyzes the conversion of T4 to bioactive T3. T3 not only stimulates adaptive thermogenesis but also affects adipose tissue (AT) lipid accumulation, mitochondrial function, inflammation, and potentially systemic metabolism. Although better defined in brown...

Full description

Saved in:
Bibliographic Details
Main Authors: David Bradley, Joey Liu, Alecia Blaszczak, Valerie Wright, Anahita Jalilvand, Bradley Needleman, Sabrena Noria, David Renton, Willa Hsueh
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/2464652
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567112959262720
author David Bradley
Joey Liu
Alecia Blaszczak
Valerie Wright
Anahita Jalilvand
Bradley Needleman
Sabrena Noria
David Renton
Willa Hsueh
author_facet David Bradley
Joey Liu
Alecia Blaszczak
Valerie Wright
Anahita Jalilvand
Bradley Needleman
Sabrena Noria
David Renton
Willa Hsueh
author_sort David Bradley
collection DOAJ
description Deiodinase type II (D2), encoded by DIO2, catalyzes the conversion of T4 to bioactive T3. T3 not only stimulates adaptive thermogenesis but also affects adipose tissue (AT) lipid accumulation, mitochondrial function, inflammation, and potentially systemic metabolism. Although better defined in brown AT, the precise role of DIO2 expression in white AT remains largely unknown, with data derived only from whole fat. Therefore, the purpose of this study was to determine whether subcutaneous (SAT) and visceral (VAT) adipocyte-specific gene expression of DIO2 differs between obese and lean patients and whether these differences relate to alterations in mitochondrial function, fatty acid flux, inflammatory cytokines/adipokines, and ultimately insulin sensitivity. Accordingly, adipocytes of 73 obese and 21 lean subjects were isolated and subjected to gene expression analyses. Our results demonstrate that obese compared to lean human individuals have increased adipocyte-specific DIO2 expression in both SAT and VAT. Although higher DIO2 was strongly related to reduced fatty acid synthesis/oxidation and mitochondrial function, we found no relationship to proinflammatory cytokines or insulin resistance and no difference based on diabetic status. Our results suggest that adipocyte-derived DIO2 may play a role in weight maintenance but is likely not a major contributor to obesity-related insulin resistance.
format Article
id doaj-art-90697a75e3224393a41f38de35709620
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-90697a75e3224393a41f38de357096202025-02-03T01:02:17ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/24646522464652Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin SensitivityDavid Bradley0Joey Liu1Alecia Blaszczak2Valerie Wright3Anahita Jalilvand4Bradley Needleman5Sabrena Noria6David Renton7Willa Hsueh8Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USADiabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USADiabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USADiabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USADiabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USACenter for Minimally Invasive Surgery, Department of General Surgery, Wexner Medical Center, Ohio State University, Columbus, OH 43210, USACenter for Minimally Invasive Surgery, Department of General Surgery, Wexner Medical Center, Ohio State University, Columbus, OH 43210, USACenter for Minimally Invasive Surgery, Department of General Surgery, Wexner Medical Center, Ohio State University, Columbus, OH 43210, USADiabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, USADeiodinase type II (D2), encoded by DIO2, catalyzes the conversion of T4 to bioactive T3. T3 not only stimulates adaptive thermogenesis but also affects adipose tissue (AT) lipid accumulation, mitochondrial function, inflammation, and potentially systemic metabolism. Although better defined in brown AT, the precise role of DIO2 expression in white AT remains largely unknown, with data derived only from whole fat. Therefore, the purpose of this study was to determine whether subcutaneous (SAT) and visceral (VAT) adipocyte-specific gene expression of DIO2 differs between obese and lean patients and whether these differences relate to alterations in mitochondrial function, fatty acid flux, inflammatory cytokines/adipokines, and ultimately insulin sensitivity. Accordingly, adipocytes of 73 obese and 21 lean subjects were isolated and subjected to gene expression analyses. Our results demonstrate that obese compared to lean human individuals have increased adipocyte-specific DIO2 expression in both SAT and VAT. Although higher DIO2 was strongly related to reduced fatty acid synthesis/oxidation and mitochondrial function, we found no relationship to proinflammatory cytokines or insulin resistance and no difference based on diabetic status. Our results suggest that adipocyte-derived DIO2 may play a role in weight maintenance but is likely not a major contributor to obesity-related insulin resistance.http://dx.doi.org/10.1155/2018/2464652
spellingShingle David Bradley
Joey Liu
Alecia Blaszczak
Valerie Wright
Anahita Jalilvand
Bradley Needleman
Sabrena Noria
David Renton
Willa Hsueh
Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
Journal of Diabetes Research
title Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
title_full Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
title_fullStr Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
title_full_unstemmed Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
title_short Adipocyte DIO2 Expression Increases in Human Obesity but Is Not Related to Systemic Insulin Sensitivity
title_sort adipocyte dio2 expression increases in human obesity but is not related to systemic insulin sensitivity
url http://dx.doi.org/10.1155/2018/2464652
work_keys_str_mv AT davidbradley adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT joeyliu adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT aleciablaszczak adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT valeriewright adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT anahitajalilvand adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT bradleyneedleman adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT sabrenanoria adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT davidrenton adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity
AT willahsueh adipocytedio2expressionincreasesinhumanobesitybutisnotrelatedtosystemicinsulinsensitivity